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births. Mothers who delivered outside a health facility experienced 1.85 times 
higher odds of experiencing neonatal deaths (adjusted odds ratio = 1.85; 95% 
confidence interval=1.33−2.58) than those who delivered in a health facility. 
CONCLUSIONS: Place of delivery is a significant predictor of neonatal mortality. 
Pregnant women need to be encouraged to deliver at health facilities and this 
should be done by intensifying education on where to deliver. Infrastructure, 
such as emergency transport, to facilitate health facility deliveries also requires 
urgent attention.  
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OBJECTIVES: Abdominal aortic aneurysm (AAA) is typically asymptomatic, but 
over time may lead to a rupture of the aorta, with a high fatality rate. Starting in 
2007, Medicare offers a new preventative service as part of its Welcome to 
Medicare visit (WTM), a free one-time AAA screening for men with smoking 
history, and both men and women with a family history of AAA. However, 
screening utilization rates are extremely low, at less than 1% of the eligible 
population. This study aims to estimate how increased utilization could affect 
population health as measured in terms of additional life years. We also explore 
the impact of extending the screening benefit to women with smoking history. 
METHODS: We created a simulation model to estimate the effects of AAA 
screening newly enrolled Medicare beneficiaries with risk factors in the primary 
care setting. Parameter estimates for AAA epidemiology, treatment patterns, and 
outcomes were based on published data. We performed univariate and 
multivariate probabilistic sensitivity analyses to test model robustness. 
RESULTS: We estimate that screening could increase life expectancy by 0.10-0.11 
and 0.26 life years for men with smoking history, men with family history of 
AAA, and women, respectively. For individuals with detected AAA, screening 
saved 1.79-2.01 and 2.88 life years in men with smoking history, men with family 
history of AAA and women, respectively, boosting corresponding 10-year 
survival rates by 9.9 - 11% and 14.5%. For women with smoking history, potential 
gains were 2.39 life years among individuals with AAA. These findings were 
robust over a range of scenarios, including assumptions about AAA epidemiology 
and outcomes in women, which are less well studied. CONCLUSIONS: Higher 
utilization of AAA screening would substantially increase life expectancy. 
Expanding the AAA screening benefit to women with smoking history could also 
yield substantial health benefits.  
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OBJECTIVES: Although the incidence of gastric cancer has declined worldwide, in 
Eastern Asia, a high incidence of gastric cancer is observed and remains a 
serious burden. Gastric cancer screening has been conducted as a national 
program in Korea and Japan. Although radiographic screening for gastric cancer 
has been conducted in Japan, it is anticipated that endoscopy will become a new 
screening method because of its high detection rate. The sensitivities of 
endoscopic and radiographic screening were calculated by the detection method 
and the incidence method based on the results of community-based screening in 
Japan. METHODS: There were 56,676 screenings for gastric cancer using 
endoscopy and radiography from April 2002 to March 2007 in Yonago, Japan. The 
target age group was from 40 to 79 years. Screen-detected and interval cancers 
were investigated based on a screening database linked to the Tottori Cancer 
Registry. All gastric cancers diagnosed within 1 year after a negative screen were 
considered interval cancers. Based on the screening history, these were divided 
into prevalence screening and incidence screening. RESULTS: Prevalence 
screenings included 7,388 for endoscopic screening and 5,410 for radiographic 
screening, while incidence screenings included 18,021 for endoscopic screening 
and 11,417 for radiographic screening. The sensitivity of prevalence screening 
calculated by the incidence method was 0.886 (95%CI: 0.698-0.976) for endoscopic 
screening and 0.831 (95%CI: 0.586-0.964) for radiographic screening, but the 
difference was not significant (p=0.626). The sensitivity of incidence screening 
calculated by the incidence method was 0.954 (95%CI: 0.842-0.994) for endoscopic 
screening and 0.855 (95%CI: 0.637-0.970) for radiographic screening (p=0.177). 
CONCLUSIONS: Endoscopic screening for gastric cancer had a higher sensitivity 
than radiographic screening by the incidence method in both screening rounds. 
However, further study is needed to evaluate mortality reduction and estimate 
overdiagnosis with endoscopic screening for gastric cancer.  
 
PHS137  
DISPENSING PRACTICES AT COMMUNITY PHARMACIES: A CROSS SECTIONAL 
STUDY FROM PAKISTAN  
Hussain A1, Ibrahim MI2, Malik M3 
1Hamdard University, Islamabad, Pakistan, 2College of Pharmacy, Qatar University, Doha, Qatar, 
3University Sains Malaysia, Hamdard University, Islamabad, Pakistan  
OBJECTIVES: To assess and compare medication counselling and dispensing 
practices at community pharmacies in three cities of Pakistan; Islamabad 
(national capital), Peshawar (the capital of Khyberpakhtoonkhwa province) and 
Lahore (the capital of Punjab province). METHODS: A total of 1113 patient-
dispenser interactions were observed from a randomly selected sample of 371 
pharmacies by using convenient sampling technique in the three respective 
cities namely Islamabad (n=118), Peshawar (n=120) and Lahore (n=133). The data 
collection tool was adapted from WHO structure observation form and was 
modified according to the objectives of the study. The data was coded, entered 
and analyzed by using SPSS Version 16. RESULTS: Out of 1113 patient-dispenser 
interactions, the providers present at the community pharmacies were: 
pharmacist (n=18, 1.6%), pharmacy assistant (n=78, 7.0%), diploma holder (n=62, 
5.6%) and salesmen (n=955, 85.8%). Prescription validation was carried out in 
18.5% of cases, drugs verification in 32.3% of cases and labelling in 6.8% of cases. 
In 40.3% of cases, dose was communicated, in 40.6% of cases frequency of 
medicine was told and in only 3.7% of cases, side effects were communicated to 
the patients/customers. Overall, only 35 (3.1%) patients were counselled 
completely about their medication, while 582 (52.7%) patients were not provided 
with any medication counselling. CONCLUSIONS: The process of medication 
counselling and dispensing practices at community pharmacies in Pakistan is 
not satisfactory. The patients are largely handled by unqualified salesmen who 
are also involved in product substitution which is beyond their work scope. 
Thus, there is a strong need to improve medication counselling and dispensing 
practices at community pharmacies which in turn will result in the provision of 
better patient oriented services at community pharmacies.  
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OBJECTIVES: Little is known about usual care treatment patterns and associated 
outcomes in Multicentric Castleman Disease (MCD). Information on the 
management of this disease can inform clinical practice, treatment guidelines, 
and elucidate areas of unmet medical need. The design and execution of a 
retrospective chart review study of patients with MCD are described, highlighting 
general methodological considerations for conducting chart review studies in 
rare diseases. METHODS: A multi-center, retrospective, chart review study of 59 
MCD patients (61.0% male; mean age 53.3±16.3 years) was conducted in two 
centers in the United States. All MCD cases within a defined eligibility period 
were identified. For eligible patients, medical record data were abstracted by site 
study staff; up to six months pre-index diagnosis date and up to three years of 
post-diagnosis. Anonymized data were recorded on paper case report forms 
(CRF) and entered into an electronic data capture (EDC) system. Key design 
challenges and lessons learned include: 1) site recruitment: limited number of 
participating treatment centers resulting in small study population; 2) CRF 
design: disease complexity and lack of published literature necessitated the 
involvement of MCD clinical experts with management knowledge 3) data 
abstraction: patients only seen at the site for a one-time consultation or second 
opinion resulting in minimal and missing data, making MCD diagnosis 
confirmation and eligibility criteria difficult to confirm and; 4) EDC system 
design: data from multiple clinical tests, exams and physician visits were 
collected, therefore, the EDC system must permit large volumes of data with a 
validation plan to ensure quality data. CONCLUSIONS: Acquisition of clinical 
outcomes, resource utilization and treatment pattern data through retrospective 
chart review study in a rare disease population such as MCD is challenging and 
requires an innovative approach, disease knowledge, and sufficient treatment 
centers to optimize external validity.  
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OBJECTIVES: To describe the referral audit intervention and how it was 
implemented, describe the referred women and their flow within and outside 
the referral networks, and assess the effectiveness of the audit on adherence  
to referral guidelines. METHODS: The study was based on a collaborative 
framework which focused on 12 health centers, 3 district hospitals and  
a regional hospital. Each facility had a midwife in charge of tracking referrals and 
their outcomes. Series of meeting (2 before the first cycle, 2 between cycles,  
and 1 at the end) were held and attended by the regional and district health 
teams, facility directors and the midwives. They were used to foster 
understanding and buy-in to the audit process, to train midwives how to 
complete the tracking forms, to discuss deficiencies they observed and 
recommended interventions, and to disseminate midterm and final results. 
RESULTS: Follow-up rates of referred women were high (96%) at each cycle. 
Going outside the network and by-passing were low (7%). Over time more cases 
were resolved at the district hospital level, reducing the need for a second 
referral to the regional hospital. This was accomplished by training and 
networking, adding key staff to district hospitals. By the end of cycle 2, 
facilitation of referral had improved, increasing adherence to referral guidelines 
CONCLUSIONS: ; An unmeasured benefit of the audit was the empowering 
experience for midwives who built new relationships, contributing to a 
strengthened sense of network and quality maternal care.  
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